FDA Inspection
CSL Plasma Inc.CSL Plasma Inc. – FDA Inspection, Jan 31, 2014
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on January 31, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CSL Plasma Inc.
- Inspection Date
- January 31, 2014
- Product Type
- Biologics
View Company Profile
ID · 524c26f7-9674-466f-905d-a07dd0086f69
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 866900
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 30, 2025 | Not classified | Kansas City District Office | |
| February 28, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 15, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 7, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 27, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Plasma Inc.
- FDA Inspection 1264259 - 2025-07-30
- FDA Inspection 1046149 - 2018-02-28
- FDA Inspection 982045 - 2016-08-15
- FDA Inspection 835125 - 2013-06-07
- FDA Inspection 729420 - 2011-05-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.